Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Sun Yat-sen University
Jiangsu HengRui Medicine Co., Ltd.
Roswell Park Cancer Institute
Merck Sharp & Dohme LLC
Radiation Therapy Oncology Group
University of Washington
Thomas Jefferson University
Bristol-Myers Squibb
CHA University
Cedars-Sinai Medical Center
Mayo Clinic
Milton S. Hershey Medical Center
University of Southern California
Eisai Inc.
BeiGene
Merck Sharp & Dohme LLC
Sanofi
Hoffmann-La Roche
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Incyte Corporation
M.D. Anderson Cancer Center
Bayer
Thomas Jefferson University
Thomas Jefferson University
Ethicon, Inc.
Fundacion Clinic per a la Recerca Biomédica
BeiGene
Imperial College London
Boston Scientific Corporation
Bristol-Myers Squibb
University of California, San Francisco
Sirtex Medical
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
TopAlliance Biosciences
Chinese University of Hong Kong
BeiGene
BeiGene
Canadian Cancer Trials Group
Novartis
Beijing YouAn Hospital
Beijing YouAn Hospital
Merck Sharp & Dohme LLC
Imunon
National Cancer Institute (NCI)
Amgen
Ethicon, Inc.
HKGepitherapeutics
Loma Linda University
Dartmouth-Hitchcock Medical Center